Susheel K. Kodali, M.D.

FDA establishment 3009978491, New York, New York, United States. Every inspection FDA has posted for the site, with its outcome and cited regulations.

Inspections: 3
Official action indicated: 0
Last inspection ended: Nov 26, 2025
Warning letters: 0

Inspections by Fiscal Year

FY2018 to FY2027 to date; 0 classified OAI

02019

02021

02023

02025

02027

Most Cited at This Site

Inspections citing each reference

21 CFR 812.150(a)(1): Investigator report of unanticipated adverse effects1

Inspections

3 inspections, newest first

Ended	Product and area	Citations	Classification
Nov 26, 2025	Devices · Bioresearch Monitoring	1 cited reference 21 CFR 812.150(a)(1). Investigator report of unanticipated adverse effects A complete and accurate report of an unanticipated adverse device effect was not prepared and submitted within 10 working days after first learning of the effect to the sponsor.	Voluntary Action Indicated (VAI)
Nov 20, 2019	Devices · Bioresearch Monitoring	None posted	No Action Indicated (NAI)
Jan 31, 2013	Devices · Bioresearch Monitoring	None posted	No Action Indicated (NAI)

Identifiers

FEI number: 3009978491
FDA firm profile: Data Dashboard

An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard and warning letters